This $15M Body-Scanning Breakthrough Could Change Your Weight Loss Journey Forever! Don’t Miss Out!

Bodd, a Melbourne-based startup known for its innovative non-invasive 3D body-scanning technology, has recently secured $15 million in new funding to expand its operations. This oversubscribed funding round was led by U.S. investors Blue Sky Capital and Ellerston Capital, and follows an earlier capital raise of $5 million in early 2023.

The company is set to use this new capital to establish a stronger presence in the United States, aiming to penetrate various sectors, including aviation, defense, and healthcare. Bodd has already made strides in these fields, having recently won a contract with United Airlines. Furthermore, its plans extend to the U.K. and the Middle East, where it aims to diversify its offerings, including contracts in law enforcement.

Originally, Bodd's technology was developed to address sizing issues associated with made-to-order clothing, a venture that the founders, Rob Fisher and David McLaughlin, sold in 2023. However, the startup is now focusing on consumer health. Bodd intends to introduce its body-scanning devices in Australian pharmacies to assist weight-loss patients who are taking GLP-1 medications. These devices can provide crucial health metrics, including body fat percentage, BMI, and water retention, all of which are vital for comprehensive health management.

In the fitness sector, Bodd's data-driven body analysis is designed to enhance member relationships and provide actionable insights for training and nutrition programs. The technology is capable of capturing vital signs such as blood pressure and heart rate, as well as measuring full-body range of motion, which can be instrumental in early injury detection and prevention.

"You’ll see Bodd very soon in a number of different pharmacies in different parts of the world," said Bodd CEO Rob Fisher in a recent interview with Amazon Web Services executives. He highlighted that the platform’s infrastructure is built on AWS, indicating a solid technological foundation for future growth.

Bodd's entrance into the fitness and health markets aligns with a growing trend in the U.S., where body-scanning technology is increasingly being adopted to improve engagement and retention within fitness facilities. For instance, Anytime Fitness utilizes Evolt scanners to provide members with thorough composition data to inform their coaching plans. Similarly, Snap Fitness has partnered with Spren to offer AI-driven body scans via smartphones, illustrating the technological evolution in health and fitness.

As Bodd prepares to roll out its body-scanning technology, the implications for both healthcare and fitness sectors could be profound. The ability to deliver precise body metrics in pharmacies and gyms can not only empower individuals on their health journeys but also bridge the gap between traditional healthcare appointments and telehealth services. By introducing these devices into everyday settings, Bodd is tapping into a critical demand for accessible health technology that serves both preventive and performance-oriented purposes.

In summary, Bodd is embarking on an ambitious journey that seeks to redefine how we approach body metrics in both health and fitness. With their recent funding and expanding partnerships, the startup is poised to make a significant impact on consumer health management and personal wellness initiatives across the globe.